Sign in

CIK 0001357459

  • Non-accelerated filer
  • Smaller reporting company

PALISADE BIO, INC.

Sign in to watch
Ticker
PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522007292
Phone
+1 858-704-4900
Business address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Former names
PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
Open-market buys, last 90 days
$28,800
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Williams Donald Allen +$29K Director 1 filing

Reading 87 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-08-16 Hallam Thomas Chief Executive Officer Purchase +40,000 $0.25 $10K 57,592
2022-08-16 Hallam Thomas Chief Executive Officer Purchase · Series 1 Common Stock Purchase Warrant +40,000 40,000
2022-08-16 Hallam Thomas Chief Executive Officer Purchase · Series 2 Common Stock Purchase Warrant +40,000 40,000
2022-03-28 Hallam Thomas Chief Executive Officer Purchase +10,000 $1.18 $12K 17,592
2022-02-17 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (right to buy) +156,600 156,600
2021-11-18 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (right to buy) +267,868 267,868
2021-09-21 Hallam Thomas Chief Executive Officer Purchase +6,000 $2.49 $15K 7,592
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award +1,592 1,592
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +4,078 4,078
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +27,189 27,189
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +6,797 6,797
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +477 477
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +2,719 2,719
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +95,572 95,572
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +22,730 22,730
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +8,754 8,754
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +20,392 20,392
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +15,002 15,002
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +12,294 12,294
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +27,190 27,190

Page 1 of 1 · 20 trades